Skip to main content
. 2011 Oct 6;44(5):213–221. doi: 10.1267/ahc.11009

Fig. 5.

Fig. 5

Bar graphs showing the percentage of differentiated and integrated GFP-positive human bone marrow-derived mesenchymal stem cells. GFP-positive human bone marrow-derived mesenchymal stem cells intraocularly injected in the 1PN/5PN/10PN mouse retinas. One week after transplantation, transplanted cells showed morphological and phenotypic differentiation and integration into retina. (A) Quantification of morphologically differentiated GFP-positive human bone marrow derived-mesenchymal stem cells in vitreous and retina. There was statistically significant difference among the three group means as determined by one-way ANOVA test (P<0.05). (B) Quantification of GFP-positive human bone marrow derived-mesenchymal stem cells co-expressing MAP2ab or GFAP in vitreous and retina one week after intraocular transplantation. The asterisks indicate no statistically significant difference between GFP-positive cells co-expressing MAP2ab and GFP-positive cells co-expressing GFAP at the same postnatal age. (C) Quantification of integrated GFP-positive human bone marrow derived-mesenchymal stem cells into retina. There was statistically significant difference among the three groups as determined by one-way ANOVA test (P<0.05). Results are mean±SEM. Percentage of differentiated or integrated cells calculated as the number of differentiated or integrated cells that expressed GFP, divided by total number of surviving GFP-positive transplanted cells ×100.